Abbott Laboratories: It's No Longer A Buy For Now
Abbott Laboratories is showing strong growth potential with rising sales and EPS, though slightly overvalued. See why we are ...
Abbott Laboratories Raises Its Outlook on Strong Medical Device Sales
Key Takeaways Abbott Laboratories beat third-quarter profit and sales estimates on strong demand for its medical ...
Abbott Labs Path To Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating ...
Abbott bumps up profit forecast on strong medical device sales
Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...
Why Abbott Laboratories Stock Was a Winner on Wednesday
Investors happily greeted the latest news from Abbott Laboratories ( ABT 1.52%) on Hump Day. After the storied healthcare ...
Abbott股票因医疗技术业务表现出色而上涨，Piper Sandler称
周四，Piper Sandler调整了对Abbott Laboratories (NYSE:ABT)的展望，将目标价从之前的131美元上调至133美元，同时维持对该股票的增持评级。 这一变化是在Abbott公布第三季度业绩后做出的。该季度业绩超出了华尔街对收入和调整后每股收益(EPS)的预期，尽管其基本面收入增长略低于预期。 Abbott的医疗技术业务在第三季度表现出强劲增长，这有助于平衡营养和诊 ...
Abbott Slightly Raises Profit Forecast on Strong Medical Device Sales
(Reuters) - Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates ...
Abbott: Challenging Comparables, Unappealing Value Limit The Incentive To Go Long Ahead Of ...
Abbott Laboratories' Q3 earnings and topline growth largely expected to be in line with the Q2 trend. Find out whether ABT ...
Abbott第三季度业绩强劲,有机销售增长超8%,上调全年指引
Abbott Laboratories (NYSE: ABT)公布了强劲的第三季度业绩,有机销售增长超过8%,调整后每股收益为1.21美元。该公司2023年第三次上调全年指引,称强劲的设备销售是主要驱动因素。 Abbott ...